Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first... Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). 詳細を表示
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30...
The Company’s antiviral candidate for seasonal and pandemic influenza shows in vitro activity against the avian influenza A PB2 protein, whereas current influenza vaccines offer no protection...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.47 | 22.9268292683 | 2.05 | 2.69 | 1.9 | 75806 | 2.3701269 | CS |
4 | 0.3119 | 14.1252660658 | 2.2081 | 2.69 | 1.81 | 30715 | 2.2294056 | CS |
12 | 0.79 | 45.6647398844 | 1.73 | 2.69 | 1.65 | 23769 | 2.06862168 | CS |
26 | -0.17 | -6.31970260223 | 2.69 | 2.7804 | 1.6 | 21655 | 2.06134236 | CS |
52 | 0.73 | 40.782122905 | 1.79 | 3.1 | 1.325 | 21565 | 2.00276869 | CS |
156 | -6.18 | -71.0344827586 | 8.7 | 8.88 | 1.325 | 106638 | 5.07880399 | CS |
260 | -2.64 | -51.1627906977 | 5.16 | 49.2 | 1.325 | 2026696 | 18.89237513 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約